Association between opioid agonist therapy and testing, treatment uptake, and treatment outcomes for hepatitis C infection among people who inject drugs: a …

J Grebely, L Tran, L Degenhardt… - Clinical Infectious …, 2021 - academic.oup.com
Background People who inject drugs (PWID) experience barriers to accessing testing and
treatment for hepatitis C virus (HCV) infection. Opioid agonist therapy (OAT) may provide an …

Global cascade of care for chronic hepatitis C virus infection: A systematic review and meta‐analysis

MT Yousafzai, S Bajis, M Alavi, J Grebely… - Journal of viral …, 2021 - Wiley Online Library
Abstract The World Health Organization 2030 targets for hepatitis C virus (HCV) elimination
include diagnosing 90% of people with HCV and treating 80% of people diagnosed with …

COVID‐19, HIV and key populations: cross‐cutting issues and the need for population‐specific responses

J Iversen, K Sabin, J Chang, RM Thomas… - African Journal of …, 2020 - journals.lww.com
Introduction: Key populations at elevated risk to contract or transmit HIV may also be at
higher risk of COVID-19 complications and adverse outcomes associated with public health …

Uptake of COVID-19 vaccination among people who inject drugs

J Iversen, H Wand, R Kemp, J Bevan, M Briggs… - Harm reduction …, 2022 - Springer
Background People who inject drugs (PWID) may be at elevated risk of adverse outcomes
from SARS-CoV-2 infection; however, data on COVID-19 vaccine uptake among PWID are …

Progress towards elimination of hepatitis C infection among people who inject drugs in Australia: the ETHOS Engage Study

H Valerio, M Alavi, D Silk, C Treloar… - Clinical Infectious …, 2021 - academic.oup.com
Background Evaluating progress towards hepatitis C virus (HCV) elimination is critical. This
study estimated prevalence of current HCV infection and HCV treatment uptake among …

Declining prevalence of current HCV infection and increased treatment uptake among people who inject drugs: the ETHOS Engage study

H Valerio, M Alavi, A Conway, D Silk, C Treloar… - International Journal of …, 2022 - Elsevier
Background Evaluating trends in HCV treatment and prevalence is crucial for monitoring
elimination. We evaluated the change in current infection and treatment among people who …

Evaluation of the Xpert HCV VL Fingerstick point-of-care assay and dried blood spot HCV-RNA testing as simplified diagnostic strategies among people who inject …

V Saludes, A Antuori, JV Lazarus, C Folch… - International Journal of …, 2020 - Elsevier
Background Catalonia requires decentralized and simplified strategies for the diagnosis of
viremic HCV infection among people who inject drugs (PWID). We aimed to perform a direct …

Hepatitis C virus testing, liver disease assessment and treatment uptake among people who inject drugs pre‐and post‐universal access to direct‐acting antiviral …

S Bajis, J Grebely, B Hajarizadeh… - Journal of viral …, 2020 - Wiley Online Library
Gaps in hepatitis C virus (HCV) testing, diagnosis, liver disease assessment and treatment
uptake among people who inject drugs (PWID) persist. We aimed to describe the cascade of …

High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia

H Valerio, M Alavi, M Law, S Tillakeratne, J Amin… - Journal of …, 2021 - Elsevier
Background & Aims High HCV treatment uptake among people at most risk of transmission
is essential to achieve elimination. We aimed to characterise subpopulations of people with …

Real-world hepatitis C treatment outcomes and reinfections among people who inject drugs at a needle and syringe program in Stockholm, Sweden

K Lindqvist, Z Thorin, M Kåberg - Harm Reduction Journal, 2023 - Springer
Background People who inject drugs (PWID) represent a population with an increased
prevalence of hepatitis C (HCV) infections. HCV treatment among PWID is essential to reach …